This study aimed to determine the risk of clinically significant biochemical hypoglycemia (CSBH) by HbA1c, gestational weight gain, C-peptide, mean capillary plasma glucose, and total insulin dose in pregnant women with type 1 diabetes mellitus in each trimester of pregnancy. This evidence concerns the gene INS and type 1 diabetes mellitus.